<p>Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial.</p>

Darshan H. Brahmbhatt, Podcast Editor of JACC: Advances, discusses a recently published original research paper on FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial.

FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial | JACC: Advances

In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.

Share FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial | JACC: Advances

Sign up to save your podcasts

FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial | JACC: Advances

FGF-23, hsCRP, Cardiovascular Events, and the Benefit of Canagliflozin in the CANVAS Trial | JACC: Advances

More shows like JACC Specialty Journals

JAMA Editors' Summary

NEJM This Week

JAMA Clinical Reviews

JACC This Week

This Week in Cardiology

Mayo Clinic Talks

The Curbsiders Internal Medicine Podcast

Eagle's Eye View: Your Weekly CV Update From ACC.org

Core IM | Internal Medicine Podcast

Annals On Call Podcast

JAMA Medical News

The Clinical Problem Solvers

Harrison's PodClass: Internal Medicine Cases and Board Prep

Cardionerds: A Cardiology Podcast

The Curious Clinicians